Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

1.92
-0.1000-4.95%
Volume:309.21K
Turnover:600.13K
Market Cap:108.49M
PE:-0.92
High:2.04
Open:2.04
Low:1.87
Close:2.02
Loading ...

Sector Update: Health Care Stocks Edge Up in Afternoon Trading

MT Newswires Live
·
27 Dec 2024

TScan Shares Jump 23% on Securities Purchase Agreement

Dow Jones
·
26 Dec 2024

Sector Update: Health Care Stocks Steady Premarket Thursday

MT Newswires Live
·
26 Dec 2024

TScan Therapeutics Signs $30 Million Direct Offering; Shares Rise Pre-Bell

MT Newswires Live
·
26 Dec 2024

TScan Therapeutics announces $30M registered direct offering

TIPRANKS
·
26 Dec 2024

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

THOMSON REUTERS
·
26 Dec 2024

Press Release: TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

Dow Jones
·
26 Dec 2024

With 52% ownership, TScan Therapeutics, Inc. (NASDAQ:TCRX) boasts of strong institutional backing

Simply Wall St.
·
25 Dec 2024

TScan Therapeutics Secures $52.5M Loan from SVB

TIPRANKS
·
23 Dec 2024

TScan Therapeutics refinances existing convertible debt facility

TIPRANKS
·
23 Dec 2024

TScan Therapeutics Inc - Enters $52.5 Million Term Loan Facility With Svb

THOMSON REUTERS
·
23 Dec 2024

TScan Therapeutics Inc - Term Loans Mature on September 1, 2029

THOMSON REUTERS
·
23 Dec 2024

TScan Therapeutics Inc - Refinancing Expected to Fund Operating Plan Into Q4 2026

THOMSON REUTERS
·
23 Dec 2024

TScan Therapeutics Refinances Existing Convertible Debt Facility With Term Loan for up to $52.5 Million From Silicon Valley Bank

THOMSON REUTERS
·
23 Dec 2024

Press Release: TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

Dow Jones
·
23 Dec 2024

TScan Therapeutics Price Target Maintained With a $11.00/Share by Needham

Dow Jones
·
11 Dec 2024